Ignacio Aznar Lou
Investigador post-doc
Researcher Ignacio Aznar Lou graduated in Pharmacy in 2014 from the Universidad San Jorge de Zaragoza and obtained his PhD in Pharmacy from the University of Barcelona in 2017.
In recent years he has carried out postdoctoral stays at Southern Denmark University (Denmark) and the University of Lisbon, where he studied various techniques for assessing population drug use and evidence review.
He is currently working on several projects related to the analysis of large real world databases in the fields of pharmacoepidemiology and pharmacoeconomics.
Professional network profiles
Last Publications
- Rubio-Valera M, Carbonell-Duacastella C, Peñarrubia-María MT, Pacheco E, Gabriela-Ricciardeli P, Aznar I and Gil MM Insights on pediatric medication initiation: perceptions of caregivers and children. FRONTIERS IN PHARMACOLOGY . 16: 1612169-1612169.
- Fuente M, Cahir C, Passos VL, Bennett K, Walsh C, Hermida-González P, Peláez de Loño J, Abella MER, Baladon L, Rubio-Valera M, Serrano-Blanco A and Aznar I Identifying longitudinal medication adherence patterns of antipsychotic treatments: A real-world cohort study in Catalonia, Spain BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . : .
- Vargas I, Mogollón-Pérez AS, Eguiguren P, Torres AL, Peralta A, Rubio-Valera M, Jervelund SS, Borras JM, Dias S and Vázquez ML Understanding the health system drivers of delayed cancer diagnosis in public healthcare networks of Chile, Colombia and Ecuador: A qualitative study with health professionals, managers and policymakers. SOCIAL SCIENCE & MEDICINE . 365: 117499-117499.
Projects
- Project name:
- M-AES_Estancia en Center of Research in Pharmacoeconomics and Drug utilization (CIRFF) at University of Naples Federico Il
- Leader
- Ignacio Aznar Lou
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- MV23/00027
- Starting - finishing date:
- 2024 - 2024
- Project name:
- SALVOVAR : A EUROPEAN MULTI-DISCIPLINARY CLINICAL PROJECT MEANT TO IMPROVE THE MANAGEMENT OF PATIENTS WITH POOR PROGNOSTIC OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY: RESTORING HOPE, SALVAGING LIVES
- Leader
- Alexandra Lelia Dima
- Funding entities:
- European Commission
- Code
- 101104469
- Starting - finishing date:
- 2023 - 2028
- Project name:
- Miguel Servet (Contrato)
- Leader
- Ignacio Aznar Lou
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- CP22/00029
- Starting - finishing date:
- 2023 - 2027
News
-
Dementia cases could triple by 2050 if countries do not address the risk factors
According to a study published in The Lancet Public Health, the number of people with dementia could triple by 2050. This study is conducted by an international research team with the participation of Dr. Ai Koyanagi and Dr. Jacob Louis of Epidemiology of Mental Disorders and Aging from IRSJD.